According to the latest visiongain report "VoWLAN & Wi-Fi enabled Handsets", combination Wi-Fi and cellular handsets are expected to penetrate the market noticeably in 2005 and 2006, as Wi-Fi silicon continues to fall in cost and size, and becomes more power efficient. Initially aimed at the enterprise market, with data-only features, they expect this hybrid handset to penetrate the home and consumer markets over time as voice functions become incorporated. - October 27, 2004

With the 2004 U.S Government's DOD budget set at $379.9 billion (a $15 billion increase on 2003), the defence cuts of the 1990's are a feature of the past. Across all the major defence markets, government defence spending has increased steadily since the late 1990's. Increasingly contracts are going to firms previously involved in commercial-sector communications technology provision. - October 27, 2004

Publishing According to the latest visiongain report "Mobile Directory Services 2004-2009", the future for Directory Enquires (DQ) market is guaranteed, providing it recognises mobile phone subscribers as a key market segment. Key advances in this segment is due to grow and the need for a regulation is essential for the consumer when DQ is implemented.

- October 27, 2004

Visiongain's latest financial report 'Outsourcing to Asia' analyses the insight into offshore outsourcing in the global financial market. With companies downsizing and cost saving, the trend of outsourcing to Asia has been an option that many companies have chosen to take. Difficulties with the managing staff abroad, along with consumer groups, main concerns lie with how much of a service can be provided through another country.
- October 27, 2004

With increasing lead times and cost of drug development, companies need to find new drugs, quicker and cheaper than before. At least 50 of the 433 are "me-too" drugs, and all are based on eight chemical scaffolds. This presents how hard it is to find or make a new molecule that has an important therapeutic effect. What has become obvious is that it takes longer, costs more and is much harder to discover new drugs than it used to be. - October 27, 2004